Daymark Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-523
| Closed | -$332K | – | 570 |
|
|
2025
Q1 | $332K | Buy |
523
+180
| +52% | +$114K | 0.01% | 396 |
|
|
2024
Q4 | $244K | Sell |
343
-12
| -3% | -$8.55K | 0.01% | 449 |
|
|
2024
Q3 | $373K | Buy |
355
+60
| +20% | +$63.1K | 0.02% | 388 |
|
|
2024
Q2 | $310K | Sell |
295
-52
| -15% | -$54.7K | 0.01% | 394 |
|
|
2024
Q1 | $334K | Hold |
347
| – | – | 0.02% | 326 |
|
|
2023
Q4 | $305K | Buy |
347
+100
| +40% | +$87.8K | 0.02% | 318 |
|
|
2023
Q3 | $203K | Buy |
+247
| New | +$203K | 0.01% | 364 |
|
|
2023
Q2 | – | Sell |
-248
| Closed | -$204K | – | 385 |
|
|
2023
Q1 | $204K | Buy |
+248
| New | +$204K | 0.03% | 280 |
|